NuroKor is on a mission to revolutionise healthcare technology. To help us succeed, we need you to join us and help shape our direction. That is why we have partnered with crowdfunding platform Seedrs so that you can buy equity in our company from as little as £12.
If you’ve been looking for a way to leave your mark on the world, this is it.
*Capital at Risk. Approved by Seedrs.
When we say ‘healthcare technology’, what image does it conjure up for you? MRI machines? One of the many advanced diagnostic devices? Anything in a hospital that beeps?
All of these are understandable and are good examples, but we have something else in mind.
NuroKor develops innovative technologies that anyone can use to address their everyday problems. From pain management to optimising recovery - whether that’s from exercise or injury - we have given thousands of people around the world the support they need to do more of what they love.
We provide non-invasive and drug-free methods of managing these issues and it is our vision that one day people will reach for NuroKor as quickly as they reach for painkillers.
Don’t just take it from us though, here are some comments from people who are already experiencing the future:
“This is a great little device which works wonders on all your aches and pains. It’s portable, lightweight and very easy to use” - Claire B., NuroKor customer
“The mibody body therapy system is brilliant I’ve used it on my knees & neck where I’ve had problems for many years. It’s helped immensely I can’t recommend this enough.” - Richard H., NuroKor customer
We’re proud to say that we have come a long way on our journey so far. Our Lifetech technology currently generates most of our revenue with devices such as mibody and mitouch popular among a wide range of users.
One of the great appeals of our healthcare devices is their ultra-wearable and easy-to-use nature, meaning that they’re suitable for everyone, regardless of circumstances. We’ve even had people using them in the middle of the ocean!
When it comes to the business itself, we’ve also demonstrated remarkable growth in the short time since our foundation. We have already had sales in 10 countries, and we are aiming to build a team of over 300 sales within the US. We also had a massive 431% uplift in sales from 2020 to 2021 - proving that we can succeed even during challenging times.
However, we know that we have more potential, and that’s where your investment comes in.
When you buy equity in NuroKor, you will be adding your voice to our mission and helping shape the direction that we move in.
Now you know what our ambition is, you’re likely wondering how we’re going to achieve it and how your investment in the company will make a difference.
We currently have several intentions for how the company will move in the next phase of our operations, and full details of these can be found on our Seedrs page. In summary, we plan to :
Expand our research and development of new technologies to address a broader range of issues, including women’s health, animal health, and recovery.
This might sound ambitious - we certainly think that we are - but what we are creating is not just about the bottom line. It’s about improving the health of everyone in our society and that is what drives us to make it reality.
Simply put, NuroKor is here to support people and to develop the best technologies for doing so. Fortunately, that is something people want and we believe we have created a business model that is sustainable and scalable whilst still providing great options for users. And you can be part of this for as little as £12*.
If this isn’t enough, we have only one more question to ask you.
Imagine in 10 years’ time, bioelectronic healthcare technology is helping to solve people’s problems quickly and easily, do you want to be able to say “I helped build this”?
Head to our Seedrs page to define the future of healthcare.
*Minimum investment amount £11.60
Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future. Seedrs does not make investment recommendations to you and any investment decision should be made on the basis of the full campaign. No communications from Seedrs, through email or any other medium, should be construed as an investment recommendation. This blog post has been approved as a financial promotion by Seedrs Limited.
Seedrs Limited is authorised and regulated by the Financial Conduct Authority. Seedrs Limited is a limited company, registered in England and Wales (No. 06848016), with registered office at Churchill House, 142-146 Old Street, London EC1V 9BW.
Founded in 2018, NuroKor is a company committed to the development of bioelectronic technologies. NuroKor develops and formulates programmable bioelectronic software for clinical and therapeutic applications, in a range of easy to use, wearable devices. It provides the highest-quality products, delivering personalised pain relief and recovery support and rehabilitation to patients.